drugset / Trial / NCT03144882

Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients

NCT03144882

RandomizedParallel-groupDouble-blindPrevention

Summary

Programmed ingestion of turmeric has no adverse effects and reduces plasma level of hs-CRP, IL-6 and TNF-α accompanying with increases albumin levels in hemodialysis patients. Turmeric can be considered as an effective anti-inflammatory supplement in hemodialysis patients.

Timeline

Start
2015-02-02
Primary completion
2016-02-02
Completion
2017-02-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Curcumin Small molecule